The potential cost-effectiveness of HPV vaccination among girls in Mongolia.

ABSTRACT:

Introduction

Cervical cancer is a leading cause of cancer among women in Mongolia with an age-standardized incidence rate of 23.5 per 100,000. HPV vaccination has not been introduced nationally and Gavi co-financing support is not available in Mongolia. Extended Gavi pricing for HPV vaccine may be available from vaccine manufacturers for a number of years. To inform introduction decision-making, we evaluated the potential cost-effectiveness of HPV vaccination among girls and young women in Mongolia.

Methods

We used UNIVAC (version 1.4), a static decision model, to evaluate the health and economic outcomes of single-cohort vaccination among females from the government perspective compared to no vaccination. We modeled vaccine introduction over 10 birth cohorts starting in 202

SUBMITTER: Luvsan ME 

PROVIDER: S-EPMC9059071 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature